Case Report
Accepted on 23 Oct 2025
Tislelizumab plus Lenvatinib for hepatocellular carcinoma with hypothyroidism. A Case Report and literature review
in Cancer Immunity and Immunotherapy
Case Report
Accepted on 23 Oct 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 23 Oct 2025
in Addictive Disorders
Original Research
Accepted on 23 Oct 2025
in Signaling
Mini Review
Accepted on 23 Oct 2025
in Cell Adhesion and Migration
Original Research
Accepted on 23 Oct 2025
in Cancer Immunity and Immunotherapy
Methods
Accepted on 23 Oct 2025
in Blockchain Security and Privacy
Original Research
Accepted on 23 Oct 2025
in Clinical Nutrition
Original Research
Accepted on 23 Oct 2025
in Exercise Physiology
Case Report
Accepted on 23 Oct 2025
in Orthopedic Surgery
Clinical Trial
Accepted on 23 Oct 2025
in Ethnopharmacology
Systematic Review
Accepted on 23 Oct 2025
in Bone Research
Opinion
Accepted on 23 Oct 2025
in Race and Ethnicity
Case Report
Accepted on 23 Oct 2025
in Oncology in Veterinary Medicine
Original Research
Accepted on 23 Oct 2025
in Ethnopharmacology
Review
Accepted on 23 Oct 2025
in Ethnopharmacology
Mini Review
Accepted on 23 Oct 2025
in Experimental Pharmacology and Drug Discovery